• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Treatment of CEA-producing tumor using the CEA family tumor suppressor.

Research Project

Project/Area Number 12670183
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionFukuoka University

Principal Investigator

KULOKI Motomu  School of Medicine, Fukuoka University Lecturer, 医学部, 講師 (10131822)

Project Period (FY) 2000 – 2001
KeywordsCEA / CEACAM1 / retrovector / tumor suppressor / gene therapy / scFv
Research Abstract

The aim of this study was to investigate the tumor suppressive effect of CEACAM1 (BGPa), a member of the CEA gene family, using a retrovector that expresses the chimeric envelopeprotein containing anti-CEA scFv for targeting to CAE-expressing tumor cells. The results currently obtained are as follows :
1. cDNA for CEACAM1 was prepared from leukocyte mRNA and ligated into the retrovector expressing anti-CEA scFv (GPEscFv-env). Spent culture medium of the resultant clone PLNC-BGPa was used for infection of GPEscFv-env. After many trials using different methods, a few clones were obtained that seemed to produce the retrovector expressing anti-CEA scFv and containing CEACAM1 cDNA (GPEscFv-env/BGPa). After its properties are analysed, GPEscFv-env/BGPa will be applied for infection of CEA-producing tumor cells in vitro and in vivo.
2. When GPEscFv-env containing green fluorescent protein was given to CEA-expressing cells in vitro, fluorescence of the protein was observed in the cells. The same vector containing the suicide gene iNOS induced suppression of the growth of CEA-producing tumor implanted into nude mice, suggesting that this retrovector is able to deliver genes effectively to CEA-expressing cells in vivo, as well as in vitro.
3. The homotypic adhesion activiy of CEACAM1 is expected to be important for its tumorp suppressive activity. Therefore, the structure essential for the cell adhesion activity of CEACAM1 was investigated by preparing CEACAM1 mutants with modified sequences. Four amino acid. residues located in the N-terminal domain of CEACAM1 were identified to be critical to the homotypic adhesion activity of CEACAM1.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Kuroki, Ma.: "Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA"Anticancer Research. 20. 4067-4071 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 黒木求: "CEACAMとPSG : CEAファミリーの新しい名称と機能"最新医学. 55. 2412-2419 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Khare, P.D.: "Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase"Cancer Research. 61. 370-375 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuroki, Mo: "Identification and comparison of residues critical for cell adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8"Journal of Leukocyte Biology. 70. 543-550 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Watt, S.M.: "Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions : structural analysis of the binding site"Blood. 98. 1469-1479 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Khara, P.D.: "Tumor growth suppression by a retroviral vector displaying scFv antibody to CEA and carrying the iNOS gene"Anticancer Research. (in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 黒木求(宮坂昌之編): "接着分子ハンドブック(分担)"秀潤社. 188 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuroki Ma., Arakawa F., Khare P.D., Kuroki Mo., Liao S., Matsumoto H., Abe H., Imakiire T.: "Specific targeting strategies of cancer gene therapy using a singlechain variable fragment (scFv) with a high affinity for CEA"Anticancer Res.. 20(6A). 4067-4071 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mo Kuroki, Abe H., Imakiire T., Ma Kuroki: "CEACAM and PSG : New nomenclature and functions of the CEA gene faimly in japanese"Saishin Igaku. 55(10). 2412-2419 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Khara P.D., Liao S., Kuroki Mo., Hirose Y., Arakawa F., Nakamura K., Tomita Y., Kuroki Ma: "Specifically targeted killing of, carcinoembryonic antigen (CEA) expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase"Cancer Res.. 61(1). 370-375 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuroki Mo., Abe H., Imakiire T., Liao S., Uchida H., Yamauchi Y., Oikawa S., Kuroki Ma: "Ideitrtification and comparison of residues critical for cell adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8"J. Leukoc. Biol.. 70(4). 543-550 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Watt S.M., Teixeira A.M., Zhou G.Q., Doyonnas R., Zhang Y., Grunert F., Blumberg R.S., Kuroki Mo., Akubitz K.m., Bates P.A.: "Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions : structural analysis of the binding site"Blood. 98(5). 1469-1479 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Khare P.D., Kuroki Ma., Liao S., Hirose Y., Fujimura S., Yamauchi Y., Miyajima-Uchida H., Kuroki M.: "Tumor growth suppression by a retroviral vector displaying scFv antibody to GEA and carrying the iNOS gene"Anticancer Res.. (in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuroki Mo: "CD66.In Handbook for Cell Adhesion Moleculs (M, Miyasaka ed.)"Syujunsha (Tokyo). 113-115 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi